Biomarkers: Troponin testing--risk stratification to stratified medicine.
Journal Article (Journal Article)
Among patients with diabetes mellitus and ischaemic heart disease, high-sensitivity testing effectively identified 39.3% of patients with elevated troponin levels who were at high 5-year risk of cardiovascular death, myocardial infarction, or stroke. Compared with optimal medical therapy, revascularization did not reduce ischaemic events among patients with elevated troponin levels.
Full Text
Duke Authors
Cited Authors
- Newby, LK; Ohman, EM
Published Date
- November 2015
Published In
Volume / Issue
- 12 / 11
Start / End Page
- 625 - 626
PubMed ID
- 26440981
Electronic International Standard Serial Number (EISSN)
- 1759-5010
Digital Object Identifier (DOI)
- 10.1038/nrcardio.2015.157
Language
- eng
Conference Location
- England